MARDENT KESKLINNA HAMBAKLIINIK OÜ
Date of report 08.11.2024
MARDENT KESKLINNA HAMBAKLIINIK OÜ
keywords
- hambakirurgia
- hambaravi osutamine
MARDENT KESKLINNA HAMBAKLIINIK OÜ
Scores and ratings
Reputation score
Credit Score
Open the reports you want to print
Employees and salaries
MARDENT KESKLINNA HAMBAKLIINIK OÜ
Employee taxes and performance analysisQuarter | Labor taxes paid | Number of employees | Turnover Per Employee | Profit per employee |
---|---|---|---|---|
2024 III | ...... | ...... | ...... | ...... |
2024 II | ...... | ...... | ...... | ...... |
2024 I | ...... | ...... | ...... | ...... |
2023 IV | ...... | ...... | ...... | ...... |
2023 III | ...... | ...... | ...... | ...... |
2023 II | ...... | ...... | ...... | ...... |
2023 I | ...... | ...... | ...... | ...... |
2022 IV | ...... | ...... | ...... | ...... |
2022 III | ...... | ...... | ...... | ...... |
2022 II | ...... | ...... | ...... | ...... |
2022 I | ...... | ...... | ...... | ...... |
2021 IV | ...... | ...... | ...... | ...... |
2021 III | ...... | ...... | ...... | ...... |
2021 II | ...... | ...... | ...... | ...... |
2021 I | ...... | ...... | ...... | ...... |
2020 IV | ...... | ...... | ...... | ...... |
2020 III | ...... | ...... | ...... | ...... |
2020 II | ...... | ...... | ...... | ...... |
2020 I | ...... | ...... | ...... | ...... |
2019 IV | ...... | ...... | ...... | ...... |
2019 III | ...... | ...... | ...... | ...... |
2019 II | ...... | ...... | ...... | ...... |
2019 I | ...... | ...... | ...... | ...... |
2018 IV | ...... | ...... | ...... | ...... |
2018 III | ...... | ...... | ...... | ...... |
2018 II | ...... | ...... | ...... | ...... |
2018 I | ...... | ...... | ...... | ...... |
2017 IV | ...... | ...... | ...... | ...... |
2017 III | ...... | ...... | ...... | ...... |
2017 II | ...... | ...... | ...... | ...... |
2017 I | ...... | ...... | ...... | ...... |
2016 IV | ...... | ...... | ...... | ...... |
2016 III | ...... | ...... | ...... | ...... |
2016 II | ...... | ...... | ...... | ...... |
2016 I | ...... | ...... | ...... | ...... |
2015 IV | ...... | ...... | ...... | ...... |
2015 III | ...... | ...... | ...... | ...... |
2015 II | ...... | ...... | ...... | ...... |
2015 I | ...... | ...... | ...... | ...... |
Deciders and beneficiaries
MARDENT KESKLINNA HAMBAKLIINIK OÜ
Deciders......
Credit Score: Trustworthy
Reputation scores: 3600
Date of birth: ......
Active relations 5
24 followers
......
Credit Score: Trustworthy
Reputation scores: 3340
Date of birth: ......
Active relations 4
24 followers
......
Credit Score: Trustworthy
Reputation scores: 1590
Date of birth: ......
Active relations 2
22 followers
MARDENT KESKLINNA HAMBAKLIINIK OÜ
History of right of representationMARDENT KESKLINNA HAMBAKLIINIK OÜ
OwnersFormer owners
Beneficiaries
Volumes and values of beneficiaries' assets
Finances and assets
MARDENT KESKLINNA HAMBAKLIINIK OÜ ...
GoodwillMARDENT KESKLINNA HAMBAKLIINIK OÜ
Paid taxes and estimated average salariesMARDENT KESKLINNA HAMBAKLIINIK OÜ
Quarterly indicatorsQuarter | Turnover | Taxed turnover | Labor productivity | Labor productivity | Employees | National taxes | Labor taxes |
---|---|---|---|---|---|---|---|
2024 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2024 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2024 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2023 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2023 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2023 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2023 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2022 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2022 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2022 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2022 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2021 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2021 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2021 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2021 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2020 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2020 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2020 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2020 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2019 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2019 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2019 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2019 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2018 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2018 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2018 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2018 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2017 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2017 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2017 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2017 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2016 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2016 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2016 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2016 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2015 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2015 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2015 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2015 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
MARDENT KESKLINNA HAMBAKLIINIK OÜ
Sales revenue by business areaMARDENT KESKLINNA HAMBAKLIINIK OÜ ...
Sales revenue by countryMARDENT KESKLINNA HAMBAKLIINIK OÜ ...
Financial indicators and prognosisMARDENT KESKLINNA HAMBAKLIINIK OÜ ...
Financial raiting: "GOOD" (2024 prognosis)MARDENT KESKLINNA HAMBAKLIINIK OÜ
Annual reportsYear | Period | Submitted | Report PDF |
---|---|---|---|
2023 | 01.01.2023–31.12.2023 | 09.05.2024 | ...... |
2022 | 01.01.2022–31.12.2022 | 05.06.2023 | ...... |
2021 | 01.01.2021–31.12.2021 | 11.04.2022 | ...... |
2020 | 01.01.2020–31.12.2020 | 29.04.2021 | ...... |
2019 | 01.01.2019–31.12.2019 | 30.06.2020 | ...... |
2018 | 01.01.2018–31.12.2018 | 08.03.2019 | ...... |
2017 | 01.01.2017–31.12.2017 | 06.03.2018 | ...... |
2016 | 01.01.2016–31.12.2016 | 17.04.2017 | ...... |
2015 | 01.01.2015–31.12.2015 | 18.02.2016 | ...... |
2014 | 01.01.2014–31.12.2014 | 26.02.2015 | ...... |
2013 | 01.01.2013–31.12.2013 | 19.03.2014 | ...... |
2012 | 01.01.2012–31.12.2012 | 04.03.2013 | ...... |
2011 | 01.01.2011–31.12.2011 | 04.04.2012 | ...... |
2010 | 01.01.2010–31.12.2010 | 26.04.2011 | ...... |
Liabilities and debts
MARDENT KESKLINNA HAMBAKLIINIK OÜ
Credit score history and prognosis... €
......
Business risk classes:
Trustworthy NeutralMARDENT KESKLINNA HAMBAKLIINIK OÜ
Reports and assets-liabilities overview 08.11.2024MARDENT KESKLINNA HAMBAKLIINIK OÜ
Claims historyTotal debt claims: ...... €
...... | ...... |
MARDENT KESKLINNA HAMBAKLIINIK OÜ
Income (turnover) and expenditure (taxes paid)Quarter | Turnover | Taxed turnover | National taxes paid | Labor taxes paid | Number of employees |
---|---|---|---|---|---|
2024 III | * ...... € | ...... € | ...... € | ...... € | ...... |
2024 II | * ...... € | ...... € | ...... € | ...... € | ...... |
2024 I | * ...... € | ...... € | ...... € | ...... € | ...... |
2023 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
2023 III | * ...... € | ...... € | ...... € | ...... € | ...... |
2023 II | * ...... € | ...... € | ...... € | ...... € | ...... |
2023 I | * ...... € | ...... € | ...... € | ...... € | ...... |
2022 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
2022 III | * ...... € | ...... € | ...... € | ...... € | ...... |
2022 II | * ...... € | ...... € | ...... € | ...... € | ...... |
2022 I | * ...... € | ...... € | ...... € | ...... € | ...... |
2021 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
2021 III | * ...... € | ...... € | ...... € | ...... € | ...... |
2021 II | * ...... € | ...... € | ...... € | ...... € | ...... |
2021 I | * ...... € | ...... € | ...... € | ...... € | ...... |
2020 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
2020 III | * ...... € | ...... € | ...... € | ...... € | ...... |
2020 II | * ...... € | ...... € | ...... € | ...... € | ...... |
2020 I | * ...... € | ...... € | ...... € | ...... € | ...... |
2019 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
2019 III | * ...... € | ...... € | ...... € | ...... € | ...... |
2019 II | * ...... € | ...... € | ...... € | ...... € | ...... |
2019 I | * ...... € | ...... € | ...... € | ...... € | ...... |
2018 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
2018 III | * ...... € | ...... € | ...... € | ...... € | ...... |
2018 II | * ...... € | ...... € | ...... € | ...... € | ...... |
2018 I | * ...... € | ...... € | ...... € | ...... € | ...... |
2017 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
2017 III | * ...... € | ...... € | ...... € | ...... € | ...... |
2017 II | * ...... € | ...... € | ...... € | ...... € | ...... |
2017 I | * ...... € | ...... € | ...... € | ...... € | ...... |
2016 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
2016 III | * ...... € | ...... € | ...... € | ...... € | ...... |
2016 II | * ...... € | ...... € | ...... € | ...... € | ...... |
2016 I | * ...... € | ...... € | ...... € | ...... € | ...... |
2015 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
2015 III | * ...... € | ...... € | ...... € | ...... € | ...... |
2015 II | * ...... € | ...... € | ...... € | ...... € | ...... |
2015 I | * ...... € | ...... € | ...... € | ...... € | ...... |
MARDENT KESKLINNA HAMBAKLIINIK OÜ
Bailiff's enforcement proceedings as of 08.11.2024Bailiff's enforcement proceedings MISSING
MARDENT KESKLINNA HAMBAKLIINIK OÜ
Regulations of the Payment Order Department as of 08.11.2024Regulations of the Payment Order Department MISSING
MARDENT KESKLINNA HAMBAKLIINIK OÜ
Court orders in the register as of 08.11.2024Court order MISSING
MARDENT KESKLINNA HAMBAKLIINIK OÜ
Decisions of the Consumer Disputes Committee as of 08.11.2024Consumer disputes MISSING
MARDENT KESKLINNA HAMBAKLIINIK OÜ
Court hearings as of 08.11.2024Court hearings MISSING
MARDENT KESKLINNA HAMBAKLIINIK OÜ
Rulings as of 08.11.2024Kohtumäärus tsiviilasjas nr 2-19-111325/23
Pärnu Maakohus Haapsalu kohtumaja Haapsalus
Related companies: | |
Number of the case: | 2-19-111325/23 |
Type of procedure: | Tsiviilasi |
Court: | Pärnu Maakohus Haapsalu kohtumaja Haapsalus |
Type of solution: | Kohtumäärus |
Solution subcategory: | Kompromissimäärus |
Composition of the Court: | Ruth Sild |
Commencement of the Court case: | 28.05.2019 |
Type of procedure: | Kohtu I astme menetlus |
Commencement of proceedings: | 28.05.2019 |
Court case category: | Võlaõigus |
Keyword: | - |
Court decision date: | 11.09.2019 |
Entry into force: | 11.09.2019 |
Dissenting opinion: | |
ECLI identifier: ? |
ECLI:EE:PMK:2019:2.19.111325.14769 |
Kohtuotsus tsiviilasjas nr 2-17-7846/15
Pärnu Maakohus Haapsalu kohtumaja Haapsalus
Related companies: | |
Number of the case: | 2-17-7846/15 |
Type of procedure: | Tsiviilasi |
Court: | Pärnu Maakohus Haapsalu kohtumaja Haapsalus |
Type of solution: | Kohtuotsus |
Solution subcategory: | - |
Composition of the Court: | Reena Undrest |
Commencement of the Court case: | 18.05.2017 |
Type of procedure: | Kohtu I astme menetlus |
Commencement of proceedings: | 18.05.2017 |
Court case category: | Võlaõigus |
Keyword: | - |
Court decision date: | 28.09.2017 |
Entry into force: | 09.11.2017 |
Dissenting opinion: | |
ECLI identifier: ? |
ECLI:EE:PMK:2017:2.17.7846.22227 |
Kohtuotsus tsiviilasjas nr 2-17-3983/4
Pärnu Maakohus Haapsalu kohtumaja Haapsalus
Related companies: | |
Number of the case: | 2-17-3983/4 |
Type of procedure: | Tsiviilasi |
Court: | Pärnu Maakohus Haapsalu kohtumaja Haapsalus |
Type of solution: | Kohtuotsus |
Solution subcategory: | Tagaseljaotsus |
Composition of the Court: | Tambet Grauberg |
Commencement of the Court case: | 14.03.2017 |
Type of procedure: | Kohtu I astme menetlus |
Commencement of proceedings: | 14.03.2017 |
Court case category: | Võlaõigus |
Keyword: | - |
Court decision date: | 21.04.2017 |
Entry into force: | 27.05.2017 |
Dissenting opinion: | |
ECLI identifier: ? |
ECLI:EE:PMK:2017:2.17.3983.9552 |
MARDENT KESKLINNA HAMBAKLIINIK OÜ
Notices and announcements as of 08.11.2024Announcements MISSING
Marketing
Business network
MARDENT KESKLINNA HAMBAKLIINIK OÜ
Business networkSign in
To expand your connections, log in to the "Networks" environment
Beneficiaries network
MARDENT KESKLINNA HAMBAKLIINIK OÜ
Networks - BeneficiariesSign in
To expand your connections, log in to the "Networks" environment
Monitoring events
Filter
Dropdown
Dropdown
Neutral
Positive
Negative
No monitoring events were found
Failed to load monitoring events